Table 1 Baseline characteristics and sphingoid base concentrations for the control and diabetic group

AGE(y)

57.84 ± 11.64

63.31 ± 7.43

0.01

BMI

24.83 ± 4.00

28.97 ± 4.5

< 0.0001

Male (%)

54

84

CHOL (mM)

5.79 ± 1.26

4.82 ± 1.11

< 0.0001

HDL (mM)

1.64 ± 0.5

1.30 ± 0.33

< 0.0001

LDL (mM)

3.47 ± 0.97

2.90 ± 0.95

0.004

TG (mM)

1.48 ± 0.93

1.44 ± 0.67

0.77

CRP (mg/l)

2.01 ± 2.18

2.72 ± 4.14

0.28

SMOKING (%)

42

77

STATINS (%)

2

70

C16SO (μM)

11.06 ± 5.40

10.84 ± 8.71

0.88

C16SA (μM)

0.35 ± 0.18

0.30 ± 0.21

0.20

C18SO (μM)

79.44 ± 28.58

72.93 ± 38.76

0.34

C18SA (μM)

2.52 ± 0.91

2.22 ± 1.14

0.14

doxSO (μM)

0.12 ± 0.09

0.19 ± 0.15

0.005

doxSA (μM)

0.06 ± 0.04

0.08 ± 0.05

0.08